PDE4 inhibitors lengthened C. elegans lifespan and reduced senescence in mouse fibroblasts
In this abstract, two PDE4 inhibitors extended lifespan in the worm C. elegans, and roflumilast reduced passage-induced cellular senescence in mouse embryonic fibroblasts; the authors link these effects to PKA activation. [1]
Automatic summary · not editorially reviewed
The key findings
Two PDE4 inhibitors, roflumilast and rolipram, extended the lifespan of C. elegans in the reported experiments. [1]
Roflumilast attenuated passage-induced cellular senescence in mouse embryonic fibroblasts. [1]
The authors report that PKA activation mediates the anti-aging effects by improving mitochondrial function and alleviating oxidative stress, conserved in C. elegans and MEFs. [1]
The source at a glance
- Study type / format
- Abstract of a laboratory study in worms and cultured mouse cells
- Population / context
- C. elegans worms and mouse embryonic fibroblasts (MEFs) in laboratory experiments
- Summary based on
- Study abstract
- Original publication
- October 8, 2026
Worms and mouse fibroblasts tested with PDE4 inhibitors
The abstract describes experiments in two systems: the nematode C. elegans and mouse embryonic fibroblasts (MEFs). Two phosphodiesterase-4 (PDE4) inhibitors were studied, roflumilast and rolipram. PDE4 is described as a subfamily of enzymes that specifically breaks down cAMP. The authors state that PDE4 inhibitors are already approved for several diseases and have improved aging-related conditions, but that their precise effects on lifespan and cellular senescence were unclear.
Supporting source [1]
Longer worm lifespan; less senescence in passaged MEFs
According to the abstract, roflumilast and rolipram extended the lifespan of C. elegans. Separately, roflumilast attenuated passage-induced cellular senescence in MEFs, meaning senescence arising as the cells were repeatedly passaged in culture. The authors further report that activation of protein kinase A (PKA) mediates the anti-aging effects of the PDE4 inhibitors by improving mitochondrial function and alleviating oxidative stress, and that this mechanism is conserved in C. elegans and MEFs.
Supporting source [1]
Abstract-only evidence from worms and cultured mouse cells
These results come from an abstract; the full text was not reviewed. The lifespan finding concerns C. elegans, and the senescence finding concerns cultured MEFs, so neither is a demonstrated human lifespan or health benefit. The abstract does not report sample sizes, doses, follow-up or statistical uncertainty. The authors describe the findings as evidence of anti-aging potential, not as proof of benefit in people.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. Findings come from C. elegans and cultured mouse embryonic fibroblasts, not from people. Sample sizes, doses, follow-up and statistical uncertainty are not reported in the abstract.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Wang ZY, Zhao XJ, Gao S, Liao YX, Chen HC, Zhang MG, Li CC, Sun ZJ, Dong DL. · europepmc.org · October 8, 2026